Abstract Carbon tetrachloride (CCl 4 ) is widely used to induce liver toxicity in in vitro/in vivo models. Lipid peroxidation (LPO) begins with toxicity and affects cell viability. Recently, the beneficial effects of melatonin and Vitamin D on cell proliferation in human normal and cancer cells were found. This study was planned to evaluate antioxidant and cytoprotective activity of melatonin and Vitamin D in CCl 4 induced cytotoxicity in HepG2 and Hep3B hepatoma cell lines. Based on the cytotoxicity assay, melatonin and Vitamin D were evaluated for cytotoprotective potential against CCl 4 induced toxicity in HepG2 and Hep3B liver cell lines by monitoring cell viability, LPO and glutathione (GSH) level. Different dosages of CCl 4 (0.1, 0.2, 0.3 and 0.4 % v/v) were applied to HepG2 and Hep3B cells in order to determine the most toxic dosage of it in a time dependent manner. The same experiments were repeated with exogenously applied melatonin (MEL) and Vitamin D to groups treated with/without CCL 4 . Cell viability was determined with MTT measurements at the 2nd, 24th and 48th h. GSH content and Malondialdehyde levels were measured from the cell lysates. As a result, both melatonin and Vitamin D administration during CCl 4 exposure protected liver cells from CCl 4 induced cell damage. Increase in LPO and decrease in GSH were found in the CCl 4 groups of both cells. Contrary to these results administration of MEL and Vitamin D on cells exhibited results similar to the control groups. Therefore, melatonin and Vitamin D might be a promising therapeutic agent in several toxic hepatic diseases.
Introduction
Carbon tetrachloride (CCl 4 ) is a clear liquid that evaporates very easily, and low background levels of CCl 4 are found in air, water, and soil because of past and present releases (ATSDR 2005) . The liver is especially sensitive to CCl4 since it contains a large amount of the enzymes that modify the form of the chemical. Some of the breakdown products may attack cell proteins, interfering with the functions of the liver cells. Products that attack cell membranes may result in the death of the cells (Thrall et al. 2000) . In vivo and in vitro studies showed that inflammation and oxidative damage are the main mechanisms of CCl 4 induced toxicity (Ding et al. 2005; Wang et al. 2005; Liu et al. 2006; Hong et al. 2009 ).
The antioxidant and hepatoprotective effects of melatonin have already been investigated (CarbajoPescador et al. 2009; Fan et al. 2010) . It influences both the membrane and nucleus receptors of the cells (Martín-Renedo et al. 2008) . HepG2 and Hep3B cell lines have been shown to retain parenchymal cell morphology (Knowles et al. 1980; Zannis et al. 1981) . They can hydroxylate Vitamin D 3 compounds (Masuda et al. 1996) . One of the pharmacologic effects of 1.25(OH) 2 D 3 , the active form of Vitamin D is cell proliferative function (Eisman et al. 1989; Akhter et al. 2001) . It has been used for disorders related to proliferation (Binderup and Bramm 1988; Kragballe 1992) .
Taking into consideration the cited properties of melatonin and Vitamin D, it was hypothesized that both of these agents may accomplish the oxidative stress affecting the cell viability during CCl 4 -induced cytotoxicity. Hence, the present study focused on evaluating the hepatoprotective activity of melatonin and Vitamin D against carbon tetrachloride (CCl 4 ) induced cytotoxicity in HepG2 and Hep3B cell lines.
Materials and methods

Cell lines, chemicals and materials
Human hepatoma cell line HepG2 and Hep3B cells were obtained from the ATCC (Manassas, VA, USA). Cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) (LONZA, Basel, Switzerland), supplemented with fetal calf serum (FCS), (LONZA), L-glutamine (LONZA), streptomycin (LONZA) and penicillin (LONZA). Carbon tetrachloride (CCl 4 ), (Sigma Chemical Co., St. Louis, MO, USA) was dissolved in dimethyl sulfoxide (DMSO) (LONZA) in a serum-free DMEM (LONZA). Melatonin (Sigma) was dissolved in a volumetric mixture of 10,000 parts phosphate buffer saline (PBS) and 1 part Ethanol (96 % v/v). Melatonin and 1.25(OH) 2 D 3 (DEVA, Istanbul, Turkey) were sterilized by 0.22 lm pore size cellulose acetate membrane filters, and added to cultures at the indicated time and concentrations. CCl 4 toxicity was studied in the HepG2 and Hep3B cell lines. Cell counts were assessed by 3-[4.5-dimethylthiazol-2-yl]-2.5 diphenyltetrazolium bromide test (MTT, Sigma).
Cell culture and experimental protocol
The human hepatoma cell lines HepG2 and Hep3B were cultured in a DMEM medium supplemented with 10 % v/v FCS, 2 mmol/L L-glutamine, streptomycin (100 lg/ml) and penicillin (100 IU/ml) in a humidified atmosphere containing 5 % CO 2 at 37°C. The cells were passaged at a split ratio of 1:3 every 2-3 days. One day before the experiments, cells were seeded on 96-well microtitre plates (Sarstedt, Nümbr-echt, Germany) at 2 9 10 5 cells/ml. The cells were treated with 0.1 ml each of 0.1, 0.2, 0.3 and 0.4 % (v/v) CCl 4 dissolved in 0.25 % DMSO in a serum-free DMEM for optimizing the most toxic dosage of CCl 4 . According to the result of CCl 4 dosage, another setup was designed. Cells were seeded again on 96-well microtitre plates at 2 9 10 5 cells/ml. The groups were arranged into eight groups for both cell lines; Control MTT, a colorimetric assay based upon the ability of living cells to reduce MTT into formazan, was used for the evaluation of the effects of CCl 4 , melatonin and 1.25(OH) 2 D 3 on cell death or proliferation (at the 2nd, 24th, 48th h). Cell number % was calculated as the ratio of the cell number of the effected group vs control group (9100) at the pre-determined hour.
Determination of lipid peroxidation
Malondialdehyde (MDA), the end product of lipid peroxidation (LPO), was calculated using thio barbituric acid reactive substance (TBARS) assay with some modifications (Ohkawa et al. 1979) . After 48 h of exposure, medium was aspirated; cells were trypsinized, suspended in 0.5 ml of PBS and sonicated for 10 s. To this 0.5 ml of TCA-TBA reagent was added and heated at 100°C for 1 h. Then it was rapidly cooled in ice bath and centrifuged. The extent of LPO was quantified by computing the levels of MDA. The absorbance of color developed using 1,1,3,3-tetramethoxypropane as an external standard was calculated at 535 nm. The results were expressed as nmole MDA equivalent formed/mg protein at 37°C.
Measurement of glutathione levels
Total glutathione level was calculated by DTNB-GSSG reductase recycling assay method (Buege and Aust 1978) . After 48 h of exposure, cells were washed twice with the cooled PBS. 100 ml of 5 % (w/v) sulfosalicylic acid was added and the plate was left on ice for 10 min. Cell suspension was transferred to microtube and centrifuged at 13,000g at 4°C for 5 min. For total GSH observation, 20 ml of supernatant and 80 ml of 1 mM EDTA in 0.1 M PBS (pH7.5) was added in each well of 96-well plate. Next, 100 ml of reaction mixture (0.15 mM 5,5
0 -dithio-bis-2-nitrobenzoic acid, 0.2 mM NADPH, 1U GSH reductase) was added. Absorbance of yellow product in the well was measured at a wave length of 405 nm using the microplate reader at 30 s intervals for 10 min. The total glutathione level was determined by the kinetic method from standard curve of reduced glutathione (GSH). The results were expressed as nmole GSH per mg of protein.
Statistical analysis
Results of the experiments were analyzed by KruskalWallis followed by a multiple comparison test using SPSS 20.0. The Chi square test was implemented in relation of the categorical variable and the disparity between the groups. p \ 0.05 was accepted as statistically significant. Results are given as mean ± SEM.
Results
Toxicity of CCl 4
We designated the concentration-dependent cytotoxic effect of CCl 4 on human cell lines, HepG2 and Hep3B as a function of time. CCl 4 treatment diminished living cell number depending on the dosage. At the 0.1 % CCl 4 dosage in HepG2 cells, a minimal cytotoxic (\4 %) effect was determined. As shown in Fig. 1a , cell exposure to 0.4 % CCl 4 for up to 2 h only mildly affected cell viability as revealed by MTT measurements. However, compared to control group values calculated in untreated cells, it became apparent at the 24th and 48th h. Like HepG2 cells, Hep3B cells were affected from CCl 4 exposure in a dose and time dependent manner (p \ 0.05, Fig. 1b) .
According to these data, 0.4 % CCl 4 concentration with a high toxic impact was chosen for showing the effects of melatonin and 1.25(OH) 2 D 3 on cell viability of HepG2 and Hep3B cells.
Cell viability of HepG2 and Hep3B cells
The cell viability ratio of the control group was accepted as 100 %. Other groups were compared to the control groups. Sham control and DMSO group were the solvents of MEL and CCl 4 and these groups were planned to show if they had any effect on cell proliferation. As a result they did not exhibit remarkable alteration on cell number in HepG2 cells (p \ 0.05, Fig. 2 ). The MEL group showed its best impact on cell number at the 2nd h. Compared to the MEL group, the Vitamin D group presented the highest potency on cell number (178 %) at the 24th h. CCl 4 decreased the cell number in a time dependent manner and at the 48th h a few cells were left (27 %). In the MEL ? CCl 4 group the cell viability was protected in a time dependent manner. Even at the 48th h, the percentage of cell number was 75 %. Cell viability percentage decreased uniformly in the MEL ? CCl 4 group as time passed; while the Vitamin D ? CCl 4 group did not exhibit such a characteristic. The Vitamin D ? CCl 4 group showed its highest efficiency on cell proliferation at the 24th h similar to Vitamin D group (p \ 0.05, Fig. 2) . In Hep3B cells, sham control and DMSO groups exhibited a cell number ratio similar to the control group (p \ 0.05, Fig. 3 ). The cell numbers of MEL and Vitamin D group were determined akin to the control group and the greatest impact of the cell number percentage of both groups were found at the 24th h. CCl 4 exposure diminished cell viability of Hep3B cells in a time dependent manner and at the 48th h it was 26 %. Compared to the CCl 4 group, the MEL ? CCl 4 group of Hep3B liver cells exhibited higher cell viability ratios. The same protection against CCl 4 cytotoxicity was determined in the Vitamin D ? CCl 4 group. Even at the 48th h the cell number ratio of this group was found 78 % (p \ 0.05, Fig. 3 ).
Lipid peroxidation and antioxidant activity
Between the results of the groups in both HepG2 and Hep3B cells the highest values for LPO were observed in the CCl 4 groups (p \ 0.05, Table 1 ). The increment in MDA was found 38 % in HepG2 cells and 32 % in Hep3B cells. In the MEL ? CCl 4 groups LPO was found lower than in the Vitamin D ? CCl 4 groups in both cell lines. Similarly, as a result of CCl 4 exposure, Table 2 ). The levels of GSH in the MEL and Vitamin D alone or with CCl 4 group showed similarity to the control groups.
The chi-square test was applied to determine whether there is a significant association between the groups. Analysis of MDA values gave the following results: The relation between the control and CCl 4 groups (p = 0.007), CCl 4 and CCl 4 ? MEL groups (p = 0.021), in Hep3B cells (Fig. 4a) (Fig. 4d) were found to be statistically significant.
Discussion
The HepG2 cell line is a preferential model for studying liver toxicity and the metabolism of xenobiotics because it has similar properties to normal human hepatocytes (Krithika et al. 2009 ). The Hep3B cell line has also been shown to display preserved parenchymal cell morphology (Knowles et al. 1980; Zannis et al. 1981 ). Therefore we preferred to study the cytoprotective effects of melatonin and 1.25(OH) 2 D 3 on the cell viability of these cell lines.
The experimental hepatotoxicity induced by CCl 4 starts with LPO and results in tissue damage (Marques et al. 2012) . To see the true toxicity time, we tried different dosages of CCl 4 and determined the highest toxic value of it. Similarly to our study, CCl 4 exposure caused remarkable loss of cell viability (Harries et al. 2001; Krithika et al. 2012) , increase in LPO (Krithika et al. 2009 ) and simultaneously attenuation of GSH (Krithika et al. 2012 ) in HepG2 cells.
It has been determined that the antioxidants reduce cytotoxicity (Kim et al. 2001; Martin et al. 2008) . Melatonin is one of the widely used antioxidants for its hepatoprotective effects (Pan et al. 2006; Subramanian et al. 2007; Tahan et al. 2009 ). Low melatonin levels are connected with high cancer risk (Maestroni and Conti 1996) and the inhibition of cell proliferation depended on treatment time and dosage (Martín-Renedo et al. 2008; Carbajo-Pescador et al. 2009 ). It has been shown that in vitro, melatonin inhibits cell growth in prostate, breast and colon cancer cells, as well as in glioma, melanoma, and hepatoma cell lines (Cos et al. 2001; Martín et al. 2007; Carbajo-Pescador et al. 2009; Fan et al. 2010; Proietti et al. 2011) . In breast cancer cells, it has been noted that 10 -9 M melatonin raised the fraction of cells in G1 and reduced the number of cells in the S phase of the cell cycle after 5 days of incubation (Cos et al. 2001) . When the same dosages of melatonin were given to prostate cancer cells, increases in cell viability in the G 0 /G 1 phase and decrease in the cell population were found in the S phase after 7 days of incubation time (Marelli et al. 2000) . As a result of high concentration of melatonin exposure to human melanoma cells led to the reduction of cell viability (Cabrera et al. 2010 ). Contrary to these results, after administration of melatonin at a low, physiological concentration over \5 days, remarkable increases in cell number were observed (Cid et al. 2012 ). Similar to our results, melatonin triggered the proliferation of neural stem cells (NSCs) from fetal mouse brain in a time and dose dependent manner (Moriya et al. 2007 ). These different studies with melatonin on cell proliferation, and the existing results point out that this neurohormone exerts in HepG2 a biphasic, non-linear impact, according to its concentration and the length of the treatment. Melatonin is also responsible for protecting the intracellular level of GSH; and shows antioxidant properties both in vitro (Vijayalaxmi et al. 1995; Gulcin et al. 2002) and in vivo (Vijayalaxmi et al. 1996; Kaya et al. 1999; El-Missiry et al. 2007) against LPO. Our results demonstrated congruity to this. Vitamin D plays a significant role in cell proliferation, differentiation and apoptosis in many normal and malignant cells (DeLuca 2008; Plum and DeLuca 2009) . Lutzow-Hollow and colleagues showed that administration of calcitriol to mouse skin induced proliferation (Lutzow-Holm et al. 1993) . Proliferation of cultured keratinocytes is increased at low concentrations of 1.25-dihydroxyvitamin D (Bollag et al. 1995) . HepG2 and Hep3B cell lines are convenient in vitro models for studying the effects of physiological factors on the 25-hydroxylation of Vitamin D 3 (Tam et al. 1988) . Accordingly, HepG2 and Hep3B cells were used in this study to investigate the effects of 1.25(OH) 2 D 3 on CCl 4 cytotoxicity. Especially through these data it is clear that, individually administered melatonin and Vitamin D revealed its highest protective effect on cell viability at the 24th h of incubation time in HepG2 cells. In contrast, there have been several studies about the anti-proliferative effects of Vitamin D in cancer cells. 10 -8 mol/L 1.25(OH) 2 D 3 inhibited the cell proliferation of HepG2 cells in 5 weeks of incubation time (Akhter et al. 2001) . The treatment of human breast cancer cells (T 47D) with 10 -9 to 10 -8 M 1.25(OH) 2 D 3 resulted in a dose-and time-dependent decline in cell numbers over 6 days (Eisman et al. 1989) . Protective effects of Vitamin D from oxidative stress (Sezgin et al. 2013; Uberti et al. 2014 ) and increment in GSH content were observed (Sezgin et al. 2013; Jain and Micinski, 2013) .
As a conclusion, the highest toxic degree of CCl 4 on HepG2 and Hep3B cells was determined. Afterwards, melatonin and Vitamin D3 were given to the hepatic cell lines. It was observed that both of them protected the cells from oxidative stress. Therefore, the beneficial effects of exogenous melatonin and Vitamin D to diminish CCl 4 -induced damage would provide a new perspective for innovation in the treatment of CCl 4 intoxications.
